How a timely policy contributes to technological capability building: insights from Iran’s biopharmaceutical sector

IF 2.6 4区管理学 Q2 ENVIRONMENTAL STUDIES

Science and Public Policy Pub Date : 2024-02-29 DOI:10.1093/scipol/scae003

Amir Ghorbani, Kiarash Fartash, Abolfazl Bagheri

{"title":"How a timely policy contributes to technological capability building: insights from Iran’s biopharmaceutical sector","authors":"Amir Ghorbani, Kiarash Fartash, Abolfazl Bagheri","doi":"10.1093/scipol/scae003","DOIUrl":null,"url":null,"abstract":"Building technological capabilities is influenced by different factors, notably policies. This paper explains the co-evolution of policies, i.e. policy tools, on the technological capabilities in Iran’s biopharmaceutical sector from 1995 to 2022. By adopting a qualitative research method, we gathered primary data through thirty-nine semi-structured as well as secondary data from reports and statistics. This paper explains technological capabilities enhancement from operational capabilities to innovative capabilities based on our proposed framework, which includes six levels. While the lack of an efficient policy tools, until the mid-2000s, was decisive in the inertia of biopharmaceutical sector capabilities, a proactive policy tools in recent years led to considerable promising results in terms of manufacturing and exporting advanced biosimilar products. Our findings shed light on the role of government support in the acceleration and directionality of technological capabilities building. Achieving advanced levels of technological capabilities requires learning, international collaboration, and export-oriented policies.","PeriodicalId":47975,"journal":{"name":"Science and Public Policy","volume":"14 1","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science and Public Policy","FirstCategoryId":"91","ListUrlMain":"https://doi.org/10.1093/scipol/scae003","RegionNum":4,"RegionCategory":"管理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL STUDIES","Score":null,"Total":0}

引用次数: 0

Abstract

Building technological capabilities is influenced by different factors, notably policies. This paper explains the co-evolution of policies, i.e. policy tools, on the technological capabilities in Iran’s biopharmaceutical sector from 1995 to 2022. By adopting a qualitative research method, we gathered primary data through thirty-nine semi-structured as well as secondary data from reports and statistics. This paper explains technological capabilities enhancement from operational capabilities to innovative capabilities based on our proposed framework, which includes six levels. While the lack of an efficient policy tools, until the mid-2000s, was decisive in the inertia of biopharmaceutical sector capabilities, a proactive policy tools in recent years led to considerable promising results in terms of manufacturing and exporting advanced biosimilar products. Our findings shed light on the role of government support in the acceleration and directionality of technological capabilities building. Achieving advanced levels of technological capabilities requires learning, international collaboration, and export-oriented policies.

查看原文本刊更多论文

及时的政策如何促进技术能力建设：伊朗生物制药行业的启示

技术能力的建设受到不同因素的影响，尤其是政策的影响。本文解释了 1995 至 2022 年间政策（即政策工具）对伊朗生物制药行业技术能力的共同影响。我们采用定性研究方法，通过 39 个半结构化问卷收集了第一手数据，并从报告和统计数据中收集了第二手数据。本文根据我们提出的包括六个层次的框架，解释了从运营能力到创新能力的技术能力提升。虽然在 2000 年代中期之前，缺乏有效的政策工具对生物制药行业能力的惰性起到了决定性作用，但近年来积极的政策工具在先进生物仿制药产品的生产和出口方面取得了可观的成果。我们的研究结果揭示了政府支持在加速技术能力建设方面的作用和方向。实现先进技术能力水平需要学习、国际合作和出口导向政策。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Science and Public Policy Multiple-

CiteScore

4.50

自引率

11.10%

发文量

期刊介绍： Science and Public Policy is a leading refereed, international journal on public policies for science, technology and innovation, and on their implications for other public policies. It covers basic, applied, high, low, and any other types of S&T, and rich or poorer countries. It is read in around 70 countries, in universities (teaching and research), government ministries and agencies, consultancies, industry and elsewhere.